Marc Musson, DO
Physical Medicine & Rehabilitation · Corvallis, ORNPI 1649589896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Nalu Medical, Inc. at 36.6% of the total. 2025 is the largest year on record at $590, more than ten times the $15 reported in 2019.
Across 25 payments — averaging $32.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$302
- Boston Scientific$247
- AbbVie$75
- Tersera Therapeutics LLC$49
- Pfizer$37
- Nevro Corp.$34
- plus $80 from 4 others
What the payments were for
- Food & beverage$824100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 7 | $302 |
| Boston Scientific | 5 | $247 |
| AbbVie | 3 | $75 |
| Tersera Therapeutics LLC | 3 | $49 |
| Pfizer | 2 | $37 |
| Nevro Corp. | 1 | $34 |
| Medtronic | 1 | $23 |
| Vertex | 1 | $20 |
| Saluda Medical Americas, Inc. | 1 | $20 |
| Abbott | 1 | $17 |
How this compares
$824 in reported general payments places this provider in the 75th percentile of 85 physical medicine & rehabilitation providers in Oregon.
See all physical medicine & rehabilitation providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 265 | $5,940 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 146 | $3,712 |
| Oxycodone Hcl | 189 | $3,581 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $1,738 |
| Gabapentin | 67 | $1,381 |
| Buprenorphine Hcl | 21 | $825 |
| Tramadol Hcl | 68 | $643 |
| Celecoxib | 34 | $629 |
| Hydromorphone Hcl | 30 | $597 |
| Cyclobenzaprine Hcl | 52 | $544 |
| Methocarbamol | 30 | $540 |
| Duloxetine Hcl | 19 | $335 |
| Baclofen | 17 | $271 |
| Methadone Hcl | 19 | $262 |
| Pregabalin | 22 | $241 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Corvallis
- Matthew LucasCorvallis$3K
- Mary LindquistPortland$62K
- Ryan MastersonBend$16K
- Ashley MichaelBend$7K
- Collin GrantMedford$7K
- Jedediah RobinsonEugene$4K
- James KassubeEugene$3K
- Mathew PaluckBend$3K
- Andrew JoycePortland$2K
- Austin GrantMedford$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.